Gefitinib ('Iressa', ZD1839), a selective epidermal growth factor receptor tyrosine kinase inhibitor, inhibits pancreatic cancer cell growth, invasion, and colony formation.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples